• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酶A(2)衍生介质在肥胖中的作用

The Role of Phospholipase A(2)-derived Mediators in Obesity.

作者信息

Abbott Marcia J, Tang Tianyi, Sul Hei Sook

机构信息

Department of Nutritional Science and Toxicology, University of California, Berkeley, CA 94720 USA.

出版信息

Drug Discov Today Dis Mech. 2010 Winter;7(3-4):e213-e218. doi: 10.1016/j.ddmec.2011.01.003.

DOI:10.1016/j.ddmec.2011.01.003
PMID:21603130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3097474/
Abstract

Obesity has become an epidemic and its prevalence is increasing exponentially. A great deal of focus has been given to understanding the molecular processes that regulate obesity. The characterization of phospholipase A(2)s, especially adipose-specific PLA(2), have lead to a proposed role of their downstream products in the progression of obesity and obesity related disorders. This review summarizes recent developments in the role of PLA(2) and their downstream effects in the development of metabolic disorders.

摘要

肥胖已成为一种流行病,其患病率正呈指数级增长。人们已将大量精力集中于理解调节肥胖的分子过程。对磷脂酶A(2),尤其是脂肪特异性磷脂酶A(2)的特性研究,已使人们提出其下游产物在肥胖及肥胖相关疾病进展中的作用。本综述总结了磷脂酶A(2)的作用及其下游效应在代谢紊乱发展方面的最新进展。

相似文献

1
The Role of Phospholipase A(2)-derived Mediators in Obesity.磷脂酶A(2)衍生介质在肥胖中的作用
Drug Discov Today Dis Mech. 2010 Winter;7(3-4):e213-e218. doi: 10.1016/j.ddmec.2011.01.003.
2
Potential lipolytic regulators derived from natural products as effective approaches to treat obesity.天然产物来源的潜在脂肪分解调节剂作为治疗肥胖的有效方法。
Front Endocrinol (Lausanne). 2022 Sep 13;13:1000739. doi: 10.3389/fendo.2022.1000739. eCollection 2022.
3
Emerging roles for phospholipase A2 enzymes in cancer.磷脂酶 A2 酶在癌症中的新作用。
Biochimie. 2010 Jun;92(6):601-10. doi: 10.1016/j.biochi.2010.03.019. Epub 2010 Mar 31.
4
Obesity and kidney disease: Hidden consequences of the epidemic.肥胖与肾脏疾病:这一流行病的潜在后果
J Ren Care. 2017 Mar;43(1):3-10. doi: 10.1111/jorc.12194.
5
Phospholipase A(2) isoforms: a perspective.磷脂酶A(2)同工型:一种观点。
Cell Signal. 2003 Jul;15(7):637-65. doi: 10.1016/s0898-6568(02)00144-4.
6
Browning of Adipocytes: A Potential Therapeutic Approach to Obesity.脂肪细胞褐变:肥胖的一种潜在治疗方法。
Nutrients. 2023 May 8;15(9):2229. doi: 10.3390/nu15092229.
7
Genome-wide screening and characterization of phospholipase A (PLA)-like genes in sorghum (Sorghum bicolor L.).高粱(Sorghum bicolor L.)中类 PLA 基因的全基因组筛选和鉴定。
Planta. 2024 Jun 26;260(2):35. doi: 10.1007/s00425-024-04467-2.
8
High plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes.肥胖伴或不伴 2 型糖尿病患者血浆中磷酸酶 A2 活性、炎症标志物和 LDL 改变升高。
Obesity (Silver Spring). 2010 Oct;18(10):2023-9. doi: 10.1038/oby.2010.9. Epub 2010 Feb 4.
9
Obesity and Liver Cancer.肥胖与肝癌
Recent Results Cancer Res. 2016;208:177-198. doi: 10.1007/978-3-319-42542-9_10.
10
Inter-organ Crosstalk and the Effect on the Aging Process in Obesity.器官间的相互作用及其对肥胖衰老过程的影响。
Curr Aging Sci. 2023;16(2):97-111. doi: 10.2174/1874609816666230223110458.

引用本文的文献

1
Dietary pyruvate targets cytosolic phospholipase A2 to mitigate inflammation and obesity in mice.饮食中的丙酮酸靶向细胞溶质磷脂酶 A2,以减轻小鼠的炎症和肥胖。
Protein Cell. 2024 Sep 1;15(9):661-685. doi: 10.1093/procel/pwae014.
2
The Phospholipase A2 Superfamily: Structure, Isozymes, Catalysis, Physiologic and Pathologic Roles.磷脂酶 A2 超家族:结构、同工酶、催化作用、生理和病理作用。
Int J Mol Sci. 2023 Jan 10;24(2):1353. doi: 10.3390/ijms24021353.
3
Lipid network and moiety analysis for revealing enzymatic dysregulation and mechanistic alterations from lipidomics data.脂质组学数据分析中的脂质网络和分馏分析揭示了酶的失调和机制改变。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac572.
4
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.cPLA2 阻断通过抑制免疫抑制性肿瘤微环境来减弱 S100A7 介导的乳腺癌发生。
J Exp Clin Cancer Res. 2022 Feb 8;41(1):54. doi: 10.1186/s13046-021-02221-0.
5
Relationship Between the Gastrointestinal Side Effects of an Anti-Hypertensive Medication and Changes in the Serum Lipid Metabolome.抗高血压药物的胃肠道副作用与血清脂质代谢组变化的关系。
Nutrients. 2020 Jan 13;12(1):205. doi: 10.3390/nu12010205.
6
Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia.靶向 ROS 和 cPLA2/COX2 表达可改善内毒素血症肥胖小鼠的肾脏损伤。
Int J Mol Sci. 2019 Sep 6;20(18):4393. doi: 10.3390/ijms20184393.
7
Association between polymorphisms in and genes and development of obesity in Chinese subjects.中国人群中[具体基因名称1]和[具体基因名称2]基因多态性与肥胖发生之间的关联。
Diabetes Metab Syndr Obes. 2018 Aug 22;11:439-446. doi: 10.2147/DMSO.S161808. eCollection 2018.
8
Amelioration of obesity-related characteristics by a probiotic formulation in a high-fat diet-induced obese rat model.益生菌配方改善高脂肪饮食诱导肥胖大鼠模型的肥胖相关特征。
Eur J Nutr. 2018 Sep;57(6):2081-2090. doi: 10.1007/s00394-017-1481-4. Epub 2017 Jun 12.
9
Peptide Fraction pOh2 Exerts Antiadipogenic Activity through Inhibition of C/EBP- and PPAR- Expression in 3T3-L1 Adipocytes.肽组分pOh2通过抑制3T3-L1脂肪细胞中C/EBP和PPAR的表达发挥抗脂肪生成活性。
Biomed Res Int. 2017;2017:4826595. doi: 10.1155/2017/4826595. Epub 2017 Mar 23.
10
Cytosolic phospholipase A₂: physiological function and role in disease.胞质型磷脂酶A₂:生理功能及在疾病中的作用
J Lipid Res. 2015 Aug;56(8):1386-402. doi: 10.1194/jlr.R057588. Epub 2015 Apr 2.

本文引用的文献

1
A link between endoplasmic reticulum stress-induced β-cell apoptosis and the group VIA Ca2+-independent phospholipase A2 (iPLA2β).内质网应激诱导的β细胞凋亡与钙依赖型磷脂酶 A2 组 VIA(iPLA2β)之间的联系。
Diabetes Obes Metab. 2010 Oct;12 Suppl 2(0 2):93-8. doi: 10.1111/j.1463-1326.2010.01270.x.
2
Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice.环氧合酶-2 缺乏可减弱小鼠脂肪组织分化和炎症。
J Biol Chem. 2011 Jan 7;286(1):889-98. doi: 10.1074/jbc.M110.139139. Epub 2010 Oct 20.
3
Body mass index is associated with leukotriene inflammation in asthmatics.体重指数与哮喘患者的白三烯炎症有关。
Eur J Clin Invest. 2011 Jan;41(1):30-8. doi: 10.1111/j.1365-2362.2010.02371.x. Epub 2010 Sep 2.
4
UCP1 induction during recruitment of brown adipocytes in white adipose tissue is dependent on cyclooxygenase activity.在白色脂肪组织中募集棕色脂肪细胞时 UCP1 的诱导依赖于环氧化酶活性。
PLoS One. 2010 Jun 30;5(6):e11391. doi: 10.1371/journal.pone.0011391.
5
Prostaglandin F(2alpha) suppresses early phase of adipogenesis, but is not associated with osteoblastogenesis in mouse mesenchymal stem cells.前列腺素 F(2alpha) 抑制脂肪生成的早期阶段,但与小鼠间充质干细胞中的成骨细胞生成无关。
Prostaglandins Other Lipid Mediat. 2010 Sep;93(1-2):52-9. doi: 10.1016/j.prostaglandins.2010.06.005. Epub 2010 Jun 30.
6
Group X secretory phospholipase A2 negatively regulates adipogenesis in murine models.X 组分泌型磷脂酶 A2 负调控小鼠模型中的脂肪生成。
FASEB J. 2010 Nov;24(11):4313-24. doi: 10.1096/fj.10-154716. Epub 2010 Jun 28.
7
Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation.通过组 VIA 磷酯酶 A(2)修复线粒体膜过氧化作用保护胰岛β细胞。
Endocrinology. 2010 Jul;151(7):3038-48. doi: 10.1210/en.2010-0016. Epub 2010 May 12.
8
Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes.环氧化酶-2通过从头募集棕色脂肪细胞来控制小鼠的能量平衡。
Science. 2010 May 28;328(5982):1158-61. doi: 10.1126/science.1186034. Epub 2010 May 6.
9
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.肥胖糖尿病患者皮下脂肪组织中内源性大麻素和相关脂质浓度的差异改变。
Lipids Health Dis. 2010 Apr 28;9:43. doi: 10.1186/1476-511X-9-43.
10
Prevalence and trends in obesity among US adults, 1999-2008.美国成年人肥胖率的流行趋势及变化,1999-2008 年。
JAMA. 2010 Jan 20;303(3):235-41. doi: 10.1001/jama.2009.2014. Epub 2010 Jan 13.